Hyderabad, July 1 -- A study by AIG Hospitals, Hyderabad, published in the international journal Endoscopy, has found that Endoscopic Sleeve Gastroplasty (ESG), a 45-minute minimally invasive procedure, delivers significantly greater short-term weight loss than oral semaglutide tablets in patients with obesity.
The real-world study, titled "Endoscopic Sleeve Gastroplasty Versus Oral Semaglutide for Obesity: A Real-World Comparative Cohort Study," compared outcomes in 150 adults treated between January 2024 and April 2025. Fifty patients underwent ESG, while 100 received oral semaglutide (14 mg) along with standard lifestyle counselling.
The study found that patients who underwent ESG achieved an average 12.72 per cent total body weight lo...